Linden and Flexan Medical Holdings, LLC Announce the Acquisition of Medron Inc.

Linden and Flexan Medical Holdings, LLC Announce the Acquisition of Medron Inc.

December 5, 2016

CHICAGO, Illinois (December 5, 2016) – Flexan Medical Holdings, LLC (“Flexan”), a leading global custom rubber molding company owned by Linden Capital Partners, announced today the acquisition of Medron Inc., a medical device contract manufacturing company. Founded in 1994, Medron employs over 170 teammates across two facilities in Salt Lake City, Utah.

“We are excited to add Medron’s vast array of capabilities to our custom medical molding services,” said Jim Fitzgerald, President & CEO of Flexan. “Medron’s reputation for providing high-quality vascular access products from design to launch aligns well with our broad platform of implantable silicone components.” This acquisition supports the medical device industry’s outsourcing trend of consolidating purchasing with fewer global total solution providers, like Flexan.

“We are thrilled to partner with Flexan,” said Ron Wortley, Founder and President of Medron. “The diversity of product offerings along with strong technical teams will bring significant value to our existing and new customers. Both organizations have similar cultures; each has a tremendous focus on innovation while delivering high-quality products that address serious clinical needs for patients," noted Mr. Wortley.

“The addition of Medron significantly enhances our contract manufacturing service offerings through the combination of world class elastomer component molding, device design, secondary operation services, and diversified global manufacturing locations," said Ron Labrum, Linden Operating Partner and Chairman of Flexan.


About Flexan Medical Holdings, LLC

Founded in 1946, Flexan is a leading global manufacturer of high-precision elastomer parts that are critical components in a broad array of products and industry applications. Headquartered in Chicago, IL, Flexan has over 500 employees and three manufacturing facilities, and operates two distinct but complementary business units (FMI and Flexan). FMI delivers clean-room manufactured silicone rubber molded components for use in Class II disposable and Class III implantable medical devices. Flexan is a custom molder whose expertise in molding difficult geometries and bonding rubber to metal has earned the company the reputation as an innovative provider across numerous attractive healthcare and industrial markets. For more information, please visit www.flexan.com and www.fmimed.com.


About Medron Inc.

Since 1994, Medron has successfully served the outsourcing needs of medical device companies around the world. Medron has attracted and maintains loyal customers who rely on us for a wide range of outsourcing services, including high volume manufacturing, customer private label capability, design engineering, product development, and prototyping. Medron has extensive working expertise in a wide range of materials, including medical grade urethanes, silicones and engineering thermoplastics. Using state-of-the-art machinery, Medron creates unique solutions that meet a wide range of customer fabrication needs. For more information, please visit www.medroninc.com.


About Linden Capital Partners

Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. Linden’s strategy is based upon three elements: (i) healthcare and life science industry specialization, (ii) integrated private equity and operating expertise, and (iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit www.lindenllc.com.